Ambrilia Biopharma Inc. (TSX:AMB), a biopharmaceutical company developing innovative therapeutics in the fields of oncology and infectious diseases, announced today that it’s President and Chief Executive Officer, Hans J. Mader, will present an overview of the Company at the BIO 2006 Annual International Convention to be held in Chicago from April 9th to April 12th. This presentation will take place on Monday, April 10th, at 2:45 p.m., local time, in Room B.
